In March 2025, the company introduced new options for the immediate-to-consumer featuring of its Wegovy weight loss drug. The company set up a brand new pharmacy, known as NovoCare, which would demand prospects $499 each month for usage of the drug, lower than 50 % the cost of the drug as a result of other pharmaceutical distribution networks.[fift